Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast Carcinomas

Epidermal growth factor receptor (EGFR) signalling is a highly regulated process with a tight balance between receptor activation and inactivation in invasive breast carcinomas (IBCs) particularly in triple-negative carcinomas (TNC). Clinical trials using anti-EGFR therapies are actually performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Meseure, Didier, Drak Alsibai, Kinan, Vacher, Sophie, Hatem, Rana, Nicolas, Andre, Callens, Celine, Lerebours, Florence, Bieche, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189325/
https://www.ncbi.nlm.nih.gov/pubmed/32377505
http://dx.doi.org/10.1155/2020/9268236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189325/
https://www.ncbi.nlm.nih.gov/pubmed/32377505
http://dx.doi.org/10.1155/2020/9268236

Ejemplares similares